Your browser is no longer supported. Please, upgrade your browser.
JAZZ Jazz Pharmaceuticals plc monthly Stock Chart
JAZZ [NASD]
Jazz Pharmaceuticals plc
Index- P/E12.97 EPS (ttm)10.45 Insider Own0.70% Shs Outstand57.01M Perf Week-5.27%
Market Cap7.72B Forward P/E7.95 EPS next Y17.05 Insider Trans-6.34% Shs Float55.07M Perf Month-9.88%
Income608.80M PEG1.17 EPS next Q4.12 Inst Own93.60% Short Float6.14% Perf Quarter-2.25%
Sales2.06B P/S3.76 EPS this Y34.60% Inst Trans-1.64% Short Ratio6.83 Perf Half Y-0.70%
Book/sh53.89 P/B2.51 EPS next Y7.13% ROA11.30% Target Price175.67 Perf Year6.88%
Cash/sh18.77 P/C7.22 EPS next 5Y11.05% ROE21.10% 52W Range116.52 - 154.24 Perf YTD-9.23%
Dividend- P/FCF8.83 EPS past 5Y15.80% ROI12.20% 52W High-12.70% Beta1.19
Dividend %- Quick Ratio3.70 Sales past 5Y16.70% Gross Margin94.20% 52W Low15.56% ATR3.03
Employees1360 Current Ratio3.90 Sales Q/Q14.60% Oper. Margin31.90% RSI (14)27.92 Volatility1.94% 2.07%
OptionableYes Debt/Eq0.53 EPS Q/Q-26.20% Profit Margin29.60% Rel Volume0.66 Prev Close135.50
ShortableYes LT Debt/Eq0.51 EarningsFeb 25 AMC Payout0.00% Avg Volume495.18K Price134.65
Recom2.10 SMA20-5.87% SMA50-8.30% SMA200-1.42% Volume42,382 Change-0.63%
Jan-08-20Initiated Goldman Neutral $153
Aug-21-19Downgrade Piper Jaffray Overweight → Neutral $205 → $142
Jun-11-19Initiated Barclays Overweight $164
Mar-20-19Initiated SunTrust Buy $163
Dec-14-18Initiated Wolfe Research Peer Perform
Nov-08-18Reiterated B. Riley FBR Buy $219 → $190
Aug-08-18Reiterated Stifel Buy $180 → $205
Jul-11-18Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-23-18Reiterated H.C. Wainwright Neutral $150 → $160
Mar-19-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-03-18Initiated Leerink Partners Outperform $180
Dec-05-17Reiterated Mizuho Neutral $144 → $150
Nov-10-17Resumed H.C. Wainwright Neutral $150
Nov-08-17Reiterated RBC Capital Mkts Outperform $210 → $195
Oct-19-17Initiated FBR & Co. Buy $206
Oct-05-17Initiated Morgan Stanley Equal-Weight $155
Sep-28-17Initiated Goldman Neutral $165
Aug-25-17Initiated H.C. Wainwright Neutral $144
May-31-17Reiterated Mizuho Neutral $150 → $144
May-15-17Initiated RBC Capital Mkts Outperform $210
Feb-21-20 09:13AM  What Awaits Jazz Pharmaceuticals (JAZZ) in Q4 Earnings? Zacks
Feb-17-20 02:30AM  PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer PR Newswire
Feb-11-20 04:05PM  Jazz Pharmaceuticals to Report 2019 Fourth Quarter and Full Year Financial Results on February 25, 2020 PR Newswire
11:42AM  Highly Rated Jazz Pharmaceuticals Sees A Hike In Its Composite Rating Investor's Business Daily
Feb-03-20 03:46PM  IBD 50 Stocks To Watch: Top Drugmaker Jazz Pharma Working On New Base Investor's Business Daily
Jan-28-20 02:59AM  Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 (Revised) Zacks
Jan-27-20 12:10PM  Why Jazz (JAZZ) Could Beat Earnings Estimates Again Zacks
Jan-23-20 10:42AM  Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 Zacks
Jan-22-20 08:00AM  Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy PR Newswire
02:30AM  PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period PR Newswire
Jan-21-20 08:41AM  Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe Zacks
Jan-20-20 10:35AM  Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea PR Newswire
Jan-13-20 11:22AM  Jazz Pharmaceuticals Sees Composite Rating Improve To 96 Investor's Business Daily
10:37AM  How Did Jazz Pharmaceuticals (JAZZ) Compare Against Top Hedge Fund Stocks in 2019? Insider Monkey
Jan-10-20 08:15AM  Maintaining $140 FVE for Jazz Following Agreement With PharmaMar for Lurbinectedin in SCLC Morningstar
Jan-06-20 04:05PM  Jazz Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-02-20 10:13AM  Do You Like Jazz Pharmaceuticals plc (NASDAQ:JAZZ) At This P/E Ratio? Simply Wall St.
Jan-01-20 11:40AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Dec-31-19 11:05AM  Jazz Enrolls First Patient in Phase II/III Leukemia Study Zacks
08:21AM  Zacks.com featured highlights include: Lithia Motors, Marathon Petroleum, Meritage Homes, Jazz Pharmaceuticals and Barclays PLC Zacks
08:18AM  7 Impressive Growth Stocks to Buy for 2020 Zacks
Dec-30-19 11:50AM  Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? Zacks
09:27AM  5 High Earnings Yield Stocks for a Standout Portfolio Zacks
08:00AM  Jazz Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 2/3 Study Evaluating JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma PR Newswire
Dec-26-19 07:34AM  Create a Value-Based Portfolio With These 4 Low P/CF Stocks Zacks
Dec-24-19 11:30AM  Is Jazz Pharmaceuticals (JAZZ) Outperforming Other Medical Stocks This Year? Zacks
Dec-23-19 09:15AM  Jazz (JAZZ) Hits 52-Week High, Can the Run Continue? Zacks
09:12AM  5 Low Price-to-Book Value Stocks to Buy as 2020 Nears Zacks
Dec-19-19 08:00AM  PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S. PR Newswire
Dec-13-19 11:40AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
09:01AM  Zoetis Surges 45.3% YTD on Strong Portfolio & New Approvals Zacks
Dec-12-19 11:50AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Dec-11-19 09:15AM  Another Small Decline as We Wait on Trade Zacks
06:05AM  6 Low Price-to-Book Value Stocks to Buy in December Zacks
Dec-10-19 10:34AM  Stocks To Watch: Jazz Pharmaceuticals Sees Relative Strength Rating Jump To 83 Investor's Business Daily
09:24AM  Zacks.com featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Changyou.com Zacks
Dec-09-19 06:18AM  Create a Standout Portfolio With These 4 Low P/CF Stocks Zacks
Dec-06-19 11:46AM  Hedge Funds Got Back Into Jazz Pharmaceuticals plc (JAZZ) At The Right Time Insider Monkey
Dec-05-19 11:31AM  Jazz (JAZZ) Up 16.4% Since Last Earnings Report: Can It Continue? Zacks
08:02AM  5 Discounted PEG Stocks for GARP Investors Zacks
Dec-04-19 08:20AM  Axsome Narcolepsy Candidate Meets Phase II Goal, Stock Up Zacks
Dec-03-19 04:13PM  Why This IBD 50 Stock Stumbled After Its Rival Posted A 15% Gain Investor's Business Daily
12:45PM  3 Reasons Growth Investors Will Love Jazz (JAZZ) Zacks
Dec-02-19 09:32AM  Bullish Looking Jazz Pharmaceutical Gets a Boost From a Quant Buy Recommendation TheStreet.com
09:17AM  Zacks.com featured highlights include: Jazz Pharmaceuticals, Mr. Cooper Group, Sonic Automotive, Hibbett Sports and Jones Lang LaSalle Zacks
08:38AM  Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8% Zacks
Nov-29-19 09:39AM  Catalyst Focuses on Firdapse Label Expansion Amid Competition Zacks
07:45AM  Buy These 5 Top-Ranked Stocks With Relative Price Strength Zacks
Nov-27-19 09:30AM  JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Nov-26-19 09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Nov-25-19 05:08PM  Zoetis (ZTS) Acquires ZNLabs to Bolster Diagnostics Portfolio Zacks
08:56AM  Jazz Pharmaceuticals plc (JAZZ) Shares March Higher, Can It Continue? Zacks
Nov-22-19 08:48AM  Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session Zacks
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
09:43AM  Edited Transcript of JAZZ earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-19-19 07:50AM  Is Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) CEO Paid At A Competitive Rate? Simply Wall St.
Nov-18-19 05:34PM  Rigel Gets Positive CHMP Review for Thrombocytopenia Drug Zacks
10:17AM  Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks
09:02AM  Jazz Pharmaceuticals, Canon, Advanced Energy Industries, Inphi and Skyworks Solutions highlighted as Zacks Bull and Bear of the Day Zacks
09:01AM  Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe Zacks
07:00AM  Bull of the Day: Jazz Pharma (JAZZ) Zacks
Nov-15-19 10:20AM  Why Jazz (JAZZ) Might be Well Poised for a Surge Zacks
09:08AM  New Strong Buy Stocks for November 15th Zacks
07:04AM  Jazz Pharma's sleep disorder drug gets European panel backing Reuters
06:45AM  Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea PR Newswire
Nov-14-19 04:05PM  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences PR Newswire
Nov-12-19 09:03AM  Zacks.com featured highlights include: Lithia, KB, Anixter, Navient and Jazz Zacks
Nov-11-19 09:30AM  JAZZ or ZTS: Which Is the Better Value Stock Right Now? Zacks
08:45AM  Here is Why Growth Investors Should Buy Jazz (JAZZ) Now Zacks
08:34AM  Bet on These 5 High Earnings Yield Stocks to Book Profits Zacks
Nov-07-19 09:10AM  Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? Zacks
08:00AM  Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting PR Newswire
Nov-06-19 10:36AM  Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales Zacks
Nov-05-19 06:25PM  Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Surpass Estimates Zacks
04:05PM  Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results PR Newswire
09:29AM  Stocks That Would Have Made You Rich Today GOBankingRates
Nov-04-19 11:54AM  ImmunoGen (IMGN) Q3 Earnings & Sales Beat, Shares Rally Zacks
11:38AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
11:23AM  Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More Zacks
Nov-01-19 11:07AM  WIll Allergan (AGN) Beat Estimates This Earnings Season? Zacks
11:05AM  Is a Beat in the Cards for Mallinckrodt (MNK) in Q3 Earnings? Zacks
10:42AM  Is a Beat in the Cards for Regeneron (REGN) Q3 Earnings? Zacks
09:15AM  Bristol-Myers (BMY) Hits Fresh High: Is There Still Room to Run? Zacks
Oct-30-19 12:44PM  Guardant Health (GH) to Report Q3 Earnings: What's in Store? Zacks
09:15AM  Small Step Back Ahead of Fed, Apple Zacks
Oct-29-19 10:33AM  Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth Zacks
09:46AM  Catalyst Pharma (CPRX) to Post Q3 Earnings: What's in Store? Zacks
Oct-28-19 10:43AM  Zacks.com featured highlights include: Koppers, Alaska Air, Guess?, Lionsgate and Jazz Pharmaceuticals Zacks
Oct-25-19 09:16AM  Invest in These 5 High Earnings Yield Stocks Right Away Zacks
Oct-24-19 10:50AM  5 Drug/Biotech Stocks Likely to Surpass on Earnings in Q3 Zacks
10:39AM  Baxter (BAX) Misses Q3 Revenue Estimates, Issues Guidance Zacks
10:10AM  Why the Earnings Surprise Streak Could Continue for Jazz (JAZZ) Zacks
09:30AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Oct-22-19 04:05PM  Jazz Pharmaceuticals to Report 2019 Third Quarter Financial Results on November 5, 2019 PR Newswire
Oct-14-19 06:38PM  Hedge Funds Are Selling Jazz Pharmaceuticals Public Limited Company (JAZZ) Insider Monkey
09:15AM  Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out? Zacks
Oct-11-19 12:49PM  Jazz Starts CAR T-cell Linked Neurotoxicity Study Enrollment Zacks
Oct-10-19 04:15PM  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity PR Newswire
09:51AM  5 High Earnings Yield Stocks to Buy for a Rewarding Portfolio Zacks
Oct-09-19 08:52AM  Jazz Pharmaceuticals Enters Oversold Territory Zacks
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease, a potentially life-threatening complication of hematopoietic stem cell transplantation; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also develops Solriamfetol for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea, as well as in Phase II clinical trial for EDS associated with Parkinson's disease; Vyxeos for acute myeloid leukemia; and JZP-258 to treat EDS and cataplexy with narcolepsy and potential treatment of idiopathic hypersomnia and a chronic neurological disorder. In addition, it sells psychiatry and other products. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; and XL-protein GmbH. The company is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILLER MICHAEL PATRICKEVP, US CommercialFeb 13Sale142.181,500213,27026,571Feb 14 05:39 PM
COZADD BRUCE CChairman & CEOFeb 03Sale143.831,000143,830298,888Feb 05 04:28 PM
MILLER MICHAEL PATRICKEVP, US CommercialJan 13Sale146.781,500220,17028,071Jan 15 04:11 PM
COZADD BRUCE CChairman & CEOJan 02Sale149.611,250187,010299,888Jan 06 06:34 PM
MILLER MICHAEL PATRICKEVP, US CommercialDec 09Sale149.121,500223,68029,571Dec 10 06:06 PM
Carr PatriciaVP, Finance & PAODec 05Option Exercise123.361,667205,6417,549Dec 09 05:19 PM
Carr PatriciaVP, Finance & PAODec 05Sale148.931,749260,4855,800Dec 09 05:19 PM
O'Keefe Kenneth WDirectorDec 04Sale147.826,750997,7744,445Dec 06 07:11 PM
COZADD BRUCE CChairman & CEODec 02Sale150.0010,7501,612,500301,138Dec 04 05:51 PM
COZADD BRUCE CChairman & CEONov 05Sale130.0050065,000311,855Nov 07 06:53 PM
COZADD BRUCE CChairman & CEOOct 01Sale130.0050065,000312,355Oct 03 05:03 PM
Treacy PaulSVP, Technical OperationsAug 12Sale137.404,371600,58916,418Aug 14 05:33 PM
ENRIGHT PATRICK GDirectorAug 09Sale135.6572698,48117,663Aug 12 05:50 PM
Winningham Rick EDirectorAug 09Sale135.6572698,4824,424Aug 12 05:48 PM
Sohn Catherine A.DirectorAug 09Sale135.6572698,4828,848Aug 12 05:38 PM
Schnee ElmarDirectorAug 09Sale135.65817110,8257,197Aug 12 05:36 PM
RIEDEL NORBERT GDirectorAug 09Sale135.6572698,4827,685Aug 12 05:32 PM
O'Keefe Kenneth WDirectorAug 09Sale135.6572698,4825,644Aug 12 05:29 PM
McSharry Heather AnnDirectorAug 09Sale135.65787106,7568,637Aug 12 05:26 PM
Gray PeterDirectorAug 09Sale135.65787106,7579,315Aug 12 05:23 PM
BERNS PAUL LDirectorAug 09Sale135.6572698,4817,966Aug 12 05:07 PM
Treacy PaulSVP, Technical OperationsMar 06Sale135.411,060143,53520,649Mar 07 07:18 PM
Young Matthew P.EVP & CFOMar 06Sale135.411,152155,99236,200Mar 07 07:13 PM
Treacy PaulSVP, Technical OperationsMar 01Sale139.50874121,92321,709Mar 04 07:41 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Option Exercise46.836,666312,16946,404Feb 27 09:10 PM
Hooper Suzanne SawochkaEVP & General CounselFeb 27Sale140.006,666933,24039,738Feb 27 09:10 PM
Young Matthew P.EVP & CFOFeb 27Sale137.91884121,91227,967Feb 27 08:38 PM
Young Matthew P.EVP & CFOFeb 26Sale125.931,032129,96029,885Feb 27 08:38 PM